{'fraction_non_alphanumeric': 0.029612756264236904, 'fraction_numerical': 0.009111617312072893, 'mean_word_length': 5.559701492537314, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Comparison of Resource Utilization in the Treatment of Open‐Angle Glaucoma between Two Cities in Finland: Is More Better?

Introduction:  Glaucoma is a progressive optic neuropathy associated with neural rim loss of the optic disc and the retinal nerve fibre layer typically causing visual field (VF) deterioration. Generally, glaucomatous lesions in the eye and in the visual field progress slowly over the years. In population‐based cross‐sectional studies, the percentage of unilateral or bilateral visual impairment varied between 3–12%. In screening studies, 0.03–2.4% of patients have been found to suffer visual impairment. Glaucoma has previously been associated with substantial healthcare costs and resource consumption attributable to the treatment of the disease. The disease also causes reduction in health‐related quality of life (HRQoL) in patients with glaucoma.